We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Orders FDA to Stop Fee Collection Activities for OTC Drugmakers
HHS Orders FDA to Stop Fee Collection Activities for OTC Drugmakers
HHS has ordered the FDA to “cease further collection efforts” related to the Over-the-Counter Drug Monograph User Fee Program and has withdrawn the agency’s Dec. 29 Federal Register notice on user fee rates.